Parabilis Medicines, Inc. (PBLS) stock
PBLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$28.25−0.20 (-0.70%)
Close on Nov 17, 2026Market cap $3.49BP/E –Yield –
Parabilis Medicines EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Parabilis Medicines
Parabilis Medicines has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?